ArticleBMJ open2023
Social ecological factors and medication treatment for opioid use disorder among justice-involved rural and urban persons: the
Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 12 citations in OpenAlex.
- History of Naloxone Possession Among Rural and Urban Individuals Participating in Prison-Based Treatment: An Observational Study.Substance use & addiction journal · 2026Observational
- Beyond weak ties in prison: An investigation of core support networks of incarcerated persons.Social networks · 2026Article
- Willingness to receive medication for opioid use disorder (MOUD): A longitudinal analysis of social network support.Drug and alcohol dependence · 2025Article
- Association Between Loneliness and Mental Health Treatment Utilization in a Prison-Based Substance Use Treatment Population.Journal of correctional health care : the official journal of the National Commission on Correctional Health Care · 2025Article
- Utilization of Kentucky Syringe Service Programs in a Justice-Involved Sample of People Who Inject Drugs.Journal of drug issues · 2025Article
- An exploration of desired abstinent and non-abstinent recovery outcomes among people who use methamphetamine.Harm reduction journal · 2025Article
- Going Above and Beyond: Bridging the Gap Between Equitable Outcomes and Procedural Fairness in Health Policy Administration.Healthcare (Basel, Switzerland) · 2024Article
- Social support networks of incarcerated women with opioid use disorder: Differences associated with jail-based substance use treatment.Journal of substance use and addiction treatment · 2024Article
- The influence of familial networks and stigma on prison-based medication initiation for individuals with opioid use disorder: Clinicians' perceptions.Journal of substance use and addiction treatment · 2024Article
- Rural and urban clinician views on COVID-19's impact on substance use treatment for individuals on community supervision in Kentucky.Health & justice · 2024Article
- Barriers and facilitators to the use of medication for opioid use disorder within the criminal justice system: Perspectives from clinicians.Journal of substance use and addiction treatment · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 1 country.
Funding
Abstract
introductionThree medications are Food and Drug Administration approved for the treatment of opioid use disorder (OUD); however, these medications are underused within prisons, which elevates the risk of relapse and overdose when persons with opioid use disorder (POUD) are released. Research is scant regarding the multilevel factors associated with POUDs' willingness to initiate medication treatment for opioid use disorder (MOUD) while in prison and their continued engagement in treatment after release. Furthermore, rural and urban populations have not been compared. The METHODS AND ANALYSIS: This mixed methods study employs a social ecological framework. A prospective observational longitudinal cohort study is being conducted with 450 POUDs using survey and social network data collected in prison, immediately postrelease, 6 months postrelease and 12 months postrelease to identify multilevel rural-urban variation in key outcomes. In-depth qualitative interviews are being conducted with POUDs, prison-based treatment staff and social service clinicians. To maximise rigour and reproducibility, we employ a concurrent triangulation strategy, whereby qualitative and quantitative data contribute equally to the analysis and are used for cross-validation when examining scientific aims. ETHICS AND DISSEMINATION: The GATE study was reviewed and approved by the University of Kentucky's Institutional Review Board prior to implementation. Findings will be disseminated through presentations at scientific and professional association conferences, peer-reviewed journal publications and a summary aggregate report submitted to the Kentucky Department of Corrections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.